JP2019055026A - Insertion body with electrodes - Google Patents

Insertion body with electrodes Download PDF

Info

Publication number
JP2019055026A
JP2019055026A JP2017181205A JP2017181205A JP2019055026A JP 2019055026 A JP2019055026 A JP 2019055026A JP 2017181205 A JP2017181205 A JP 2017181205A JP 2017181205 A JP2017181205 A JP 2017181205A JP 2019055026 A JP2019055026 A JP 2019055026A
Authority
JP
Japan
Prior art keywords
electrode
balloon
bcr
shaft
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017181205A
Other languages
Japanese (ja)
Inventor
武明 新城
Takeaki SHINJO
武明 新城
浩伸 林
Hironobu Hayashi
浩伸 林
昌彦 川口
Masahiko Kawaguchi
昌彦 川口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nara Medical University
Original Assignee
Nara Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nara Medical University filed Critical Nara Medical University
Priority to JP2017181205A priority Critical patent/JP2019055026A/en
Priority to PCT/JP2018/022321 priority patent/WO2019058656A1/en
Publication of JP2019055026A publication Critical patent/JP2019055026A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/20Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/389Electromyography [EMG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/06Electrodes for high-frequency therapy

Abstract

To provide an insertion body with electrodes capable of accurate BCR monitoring.SOLUTION: An insertion body with electrodes has: an elongate shaft 100 to be inserted in the urinary tract; a balloon 200 which is arranged near an end part of the shaft 100 and can expand in the bladder; and a stimulating electrode 300 provided on a balloon base end part side which is positioned near the bladder neck when the shaft 100 is inserted in the urinary tract to stimulate the pudendal nerves.SELECTED DRAWING: Figure 1

Description

本発明は、球海綿体反射モニタリングに使用される電極付挿入体に関する。   The present invention relates to an electrode-attached insert used for spherical cavernous reflection monitoring.

膀胱直腸障害は、尿閉、残尿、失禁、排尿遅延等の症状を示す機能障害で、中枢神経や末梢神経が傷つき麻痺すること等が起因となる障害である。膀胱直腸障害のリスクがある手術としては、例えば、脊髄係留症候群の解除手術、脊髄随内腫瘍摘出術、脊柱管狭窄症解除術等の手術がある。そのためこれらの手術を行う際には手術操作による膀胱直腸障害を回避するための対策が必要となる。   Bladder and rectal disorders are functional disorders that show symptoms such as urinary retention, residual urine, incontinence, and delay in urination, and are disorders that result from injury or paralysis of the central nerve or peripheral nerve. Surgery at risk of bladder rectal disorder includes, for example, operations such as spinal cord anchorage relief surgery, intraspinal tumor removal, spinal canal stenosis relief, and the like. Therefore, when performing these operations, it is necessary to take measures to avoid bladder and rectal disorders due to the operation.

この膀胱直腸障害を回避するための対策として、球海綿体反射(以下BCR:bulbocavernous reflexと略することがある。)モニタリングがある(非特許文献1)。BCRは仙髄反射弓の一つであり、陰茎又は陰核を指でつかむか圧迫すると、球海綿体筋や肛門括約筋が収縮することをいう。非特許文献1には、BCRモニタリングにおける男性の陰部神経刺激のため、2個の輪状電極の1本を陰茎冠状溝に、もう1本を陰茎体部に巻きつける手法が記載されている。   As a measure for avoiding this bladder rectal disorder, there is monitoring of the spongiform reflex (hereinafter sometimes abbreviated as BCR: bulbocavernous reflex) (Non-patent Document 1). BCR is one of the sacral reflex arches. When the penis or clitoris is grasped or pressed with a finger, the cavernous and anal sphincter muscles contract. Non-Patent Document 1 describes a technique of winding one of two ring-shaped electrodes around the penile coronal groove and the other around the penile body for stimulating pudendal nerves in men in BCR monitoring.

またBCRモニタリングでは、刺激電極としてのシール電極を陰茎又は陰核に貼付し、筋活動電位の振幅を手術前と手術操作中とで観察し、筋活動電位が手術前と比較して例えば50%以下になれば脊髄が傷害されたと評価する手法もある。   In BCR monitoring, a seal electrode as a stimulation electrode is attached to the penis or clitoris, and the amplitude of the muscle action potential is observed before and during the operation. For example, the muscle action potential is 50% of that before the operation. There is also a technique to evaluate that the spinal cord is injured if:

しかしながらシール電極を陰茎又は陰核へ貼付した場合、患者の体動等により手術中に時間とともにシール電極が剥がれることがあり、特に女性の場合はシール貼付箇所の極小性及び湿潤環境であることもあいまってBCRモニタリングでの筋活動電位の振幅の測定が困難である(非特許文献2,非特許文献3)。   However, when the seal electrode is applied to the penis or clitoris, the seal electrode may peel off over time due to patient movement, etc., especially in the case of women, the seal application location may be minimal and moist. Together, it is difficult to measure the amplitude of the muscle action potential in BCR monitoring (Non-patent Documents 2 and 3).

術中にBCRモニタリングでの筋活動電位の振幅が低下した場合、手術操作による神経障害(真陽性)又はシール電極の剥がれ等に起因するBCRモニタリングミス(偽陽性)の何れかが考えられるが、術中にそれを正確に見極めることが困難な場合があり、実際には偽陽性の場合を真陽性であると判断を誤る場合にあっては腫瘍を完全に切除できないままで手術が中断される虞があり、かかる場合にあっては患者の不利益が著しい。   If the amplitude of my action potential in BCR monitoring decreases during surgery, either neurological damage due to surgery (true positive) or BCR monitoring mistake (false positive) due to peeling of the seal electrode, etc. may be considered. In some cases, it may be difficult to accurately determine this, and in fact, if the false positive is misjudged as true positive, the operation may be interrupted without completely removing the tumor. Yes, in such cases, the patient's disadvantage is significant.

米田勝紀 誘発筋電図法による球海綿体反射の検討 泌尿紀要30巻9号 1984年9月Yoneda Katsunori Examination of spherical cavernous reflexes by evoked electromyography Flancesco S : Intraoperative neurophysiology in tethered cord surgery : techniques and results. Child’s Nerv Syst (2013)29:1611-1624Flancesco S: Intraoperative neurophysiology in tethered cord surgery: techniques and results.Child ’s Nerv Syst (2013) 29: 1611-1624 原田直幸ら 女性や小児における脊髄疾患術中球海綿体反射(BCR)の問題点 Spinal Surgery 29(1) 81-84,2015Naoyuki Harada et al. Problems of Spherical Cavernous Reflex (BCR) in Spinal Cord Surgery in Women and Children Spinal Surgery 29 (1) 81-84,2015

本発明はかかる問題点に鑑みてなされたものであって、正確なBCRモニタリングを実現できる電極付挿入体を提供することを目的とする。   The present invention has been made in view of such problems, and an object thereof is to provide an electrode-attached body that can realize accurate BCR monitoring.

本発明にかかる電極付挿入体は、尿道内に挿入される細長いシャフトと、前記シャフトの先端部近傍に配置され、膀胱内で膨張可能なバルーンと、前記シャフトの尿道内挿入時に膀胱頸部近傍に位置して陰部神経を刺激する、バルーン基端部側に設けられる刺激電極と、を有することを特徴とする。   The electrode-attached insert according to the present invention includes an elongated shaft to be inserted into the urethra, a balloon that is disposed in the vicinity of the tip of the shaft and is inflatable in the bladder, and the vicinity of the bladder neck when the shaft is inserted into the urethra And a stimulation electrode provided on the proximal side of the balloon for stimulating the pudendal nerve.

本発明によれば、正確なBCRモニタリングが可能である。   According to the present invention, accurate BCR monitoring is possible.

本実施形態にかかる電極付挿入体の概略を説明する図である。It is a figure explaining the outline of the insertion object with an electrode concerning this embodiment. シャフト先端部を説明する図である。It is a figure explaining a shaft tip part. 陰部神経の走行状態を説明する図である。It is a figure explaining the running state of a pudendal nerve. (A)は刺激電極を陰部神経近傍に位置させた場合を説明する図であり、(B)は刺激電極を膀胱頸部近傍に位置させた場合を説明する図である。(A) is a figure explaining the case where the stimulation electrode is located near the pudendal nerve, and (B) is the figure explaining the case where the stimulation electrode is located near the bladder neck. 本実施例にかかる電極付挿入体の写真図である。It is a photograph figure of the insertion object with an electrode concerning a present Example. (A)は手術開始前における従来法及び本発明(バルーンの基端側端部と第1電極との距離Lは10mm)により測定したBCR振幅を示す図であり、(B)は手術終了後における従来法及び本発明により測定したBCR振幅を示す図である。(A) is a figure which shows the BCR amplitude measured by the conventional method and the present invention (distance L between the proximal end of the balloon and the first electrode is 10 mm) before the start of surgery, and (B) is after the end of surgery. It is a figure which shows the BCR amplitude measured by the conventional method in this and this invention. (A)は手術開始前における従来法及び本発明(バルーンの基端側端部と第1電極との距離Lは20mm)により測定したBCR振幅を示す図であり、(B)は手術終了後における従来法及び本発明により測定したBCR振幅を示す図である。(A) is a figure which shows the BCR amplitude measured by the conventional method and the present invention (distance L between the proximal end of the balloon and the first electrode is 20 mm) before the start of surgery, and (B) is after the end of surgery. It is a figure which shows the BCR amplitude measured by the conventional method in this and this invention.

以下、添付の図面を参照して本発明の実施形態について具体的に説明するが、当該実施形態は本発明の原理の理解を容易にするためのものであり、本発明の範囲は、下記の実施形態に限られるものではなく、当業者が以下の実施形態の構成を適宜置換した他の実施形態も、本発明の範囲に含まれる。   Hereinafter, embodiments of the present invention will be specifically described with reference to the accompanying drawings. However, the embodiments are for facilitating understanding of the principle of the present invention, and the scope of the present invention is as follows. The present invention is not limited to the embodiments, and other embodiments in which those skilled in the art appropriately replace the configurations of the following embodiments are also included in the scope of the present invention.

本発明者らは、陰茎や陰核等の体表にシール電極を貼付する手法では偽陽性の可能性を低減させることは困難であると考え、体表にシール電極を貼付するのではなく患者の尿道内に電極を挿入することにより体内から陰部神経を刺激する手法を考案した。また正確なBCRモニタリングの実現のためには、陰部神経に適切に電気刺激を伝える必要があるため電極を陰部神経近傍に位置させる必要があると考えられてきたが、しかし、本発明においては陰部神経から離間した位置である膀胱頸部近傍に電極を位置させて陰部神経を刺激する。   The present inventors consider that it is difficult to reduce the possibility of false positives by applying a seal electrode to the body surface such as the penis and clitoris, and instead of applying a seal electrode to the body surface, the patient We have devised a technique for stimulating the pudendal nerve from the body by inserting electrodes into the urethra. In order to realize accurate BCR monitoring, it has been considered that it is necessary to appropriately transmit electrical stimulation to the pudendal nerve, so it is necessary to position the electrode in the vicinity of the pudendal nerve. An electrode is positioned in the vicinity of the bladder neck, which is a position away from the nerve, to stimulate the pudendal nerve.

図1に示されるように、本実施形態にかかる電極付挿入体900は、尿道内に挿入される細長いシャフト100と、膀胱内で膨張可能なバルーン200と、刺激電極300と、を有する。なお、いわゆる尿道カテーテルは、尿道内に挿入される細長いシャフトと、膀胱内で膨張可能なバルーンと、を有して構成されるため、本実施形態にかかる電極付挿入体900は、刺激電極付尿道カテーテルとして構成することも可能である。   As shown in FIG. 1, the electrode-equipped insert 900 according to the present embodiment includes an elongated shaft 100 that is inserted into the urethra, a balloon 200 that is inflatable in the bladder, and a stimulation electrode 300. Since the so-called urinary catheter has an elongated shaft inserted into the urethra and a balloon that is inflatable in the bladder, the electrode-equipped insert 900 according to this embodiment includes a stimulation electrode. It can also be configured as a urinary catheter.

図2に示されるように、シャフト100は、外管120と、外管120の内部に配置された外管120よりも長手である内管110とから構成されたいわゆる2重管構造を有する。内管110はシャフト100の軸方向と異なる方向に突出する第1ハブ130に接続されており、その内部には内管110の先端部から第1ハブ130のポートまで延びる第1ルーメンが形成されている。一方、外管120はシャフト100の軸方向と同一方向に突出する第2ハブ140に接続されており、内管110の外周面と外管120の内周面との間には、外管120の先端部から第2ハブ140のポートまで延びる第2ルーメンが形成されている。第2ハブ140はバルーン200を拡張する拡張液を供給するための拡張液用である。   As shown in FIG. 2, the shaft 100 has a so-called double pipe structure including an outer pipe 120 and an inner pipe 110 that is longer than the outer pipe 120 disposed inside the outer pipe 120. The inner tube 110 is connected to a first hub 130 protruding in a direction different from the axial direction of the shaft 100, and a first lumen extending from the tip of the inner tube 110 to the port of the first hub 130 is formed therein. ing. On the other hand, the outer tube 120 is connected to a second hub 140 protruding in the same direction as the axial direction of the shaft 100, and the outer tube 120 is interposed between the outer peripheral surface of the inner tube 110 and the inner peripheral surface of the outer tube 120. A second lumen extending from the distal end of the second hub 140 to the port of the second hub 140 is formed. The second hub 140 is for expansion fluid for supplying expansion fluid for expanding the balloon 200.

なお本明細書にて用いられる「先端部」とは、器具及び装置の位置を表す用語であって当該器具又は装置を術者が使用する際に当該器具又は装置のうち操作者に遠い側の部分を指し、そして用語「基端部」とは、器具及び装置の位置を表す用語であって当該器具又は装置を術者が使用する際に当該器具又は装置のうち術者に近い側の部分を指して言う。   The “tip portion” used in this specification is a term indicating the position of the instrument and the device, and when the operator uses the instrument or the device, the distal side of the instrument or the device far from the operator is used. The term “proximal end” refers to the position of the instrument and device, and the part of the instrument or device closer to the operator when the operator uses the instrument or device. Point to and say.

シャフト100の外管120及び内管110の形成材料としては、本発明の電極付挿入体900を尿道内にて前後に動かした際に尿道内壁組織を損傷することなく安全に挿通することができるという理由から可撓性を有するものが好ましく、金属や樹脂が挙げられる。金属としては、例えば、Ni-Ti系合金のような擬弾性合金(超弾性合金を含む)、形状記憶合金、ステンレス鋼(例えば、SUS304、SUS303、SUS316、SUS316L、SUS316J1、SUS316J1L、SUS405、SUS430、SUS434、SUS444、SUS429、SUS430F、SUS302等)、コバルト系合金、金、白金のような貴金属、タングステン系合金、炭素系材料等が挙げられる。樹脂としては、例えば、ポリオレフィン(例えば、ポリエチレン、ポリプロピレン、ポリブテン、エチレン−プロピレン共重合体、エチレン−酢酸ビニル共重合体、アイオノマー、或いはこれら二種以上の混合物等)、ポリ塩化ビニル、ポリアミド、ポリアミドエラストマー、ポリエステル、ポリエステルエラストマー、ポリウレタン、ポリウレタンエラストマー、ポリイミド、フッ素樹脂等の高分子材料或いはこれらの混合物、或いは上記2種以上の高分子材料が挙げられる。   As a material for forming the outer tube 120 and the inner tube 110 of the shaft 100, when the electrode-equipped insert 900 of the present invention is moved back and forth in the urethra, it can be safely inserted without damaging the urethral inner wall tissue. For this reason, those having flexibility are preferable, and examples thereof include metals and resins. Examples of metals include pseudo-elastic alloys (including super-elastic alloys) such as Ni-Ti alloys, shape memory alloys, stainless steel (for example, SUS304, SUS303, SUS316, SUS316L, SUS316J1, SUS316J1L, SUS405, SUS430, SUS434, SUS444, SUS429, SUS430F, SUS302, etc.), cobalt alloys, gold, noble metals such as platinum, tungsten alloys, carbon materials and the like. Examples of the resin include polyolefin (for example, polyethylene, polypropylene, polybutene, ethylene-propylene copolymer, ethylene-vinyl acetate copolymer, ionomer, or a mixture of two or more thereof), polyvinyl chloride, polyamide, polyamide. Examples thereof include polymer materials such as elastomers, polyesters, polyester elastomers, polyurethanes, polyurethane elastomers, polyimides, fluororesins, mixtures thereof, and the above two or more polymer materials.

シャフト100の長さは必ずしも限定されないが、外管120の先端部から基端部までの距離は例えば1000mm〜2500mm、好ましくは1200mm〜2300mmである。また内管110の先端部から基端部までの距離は例えば1200mm〜2700mm、好ましくは1100mm〜2600mmである。内管110及び外管120は略円状の断面形状を有するが、断面形状は、必ずしも真円形状でなくてもよく、例えば、楕円形状であってもよい。外管120の平均外径は、好ましくは0.3mm〜3mmであり、好ましくは0.5mm〜2mmである。内管110の平均外径は、好ましくは0.2mm〜2.8mmであり、好ましくは0.25mm〜1.85mmである。   The length of the shaft 100 is not necessarily limited, but the distance from the distal end portion to the proximal end portion of the outer tube 120 is, for example, 1000 mm to 2500 mm, preferably 1200 mm to 2300 mm. The distance from the distal end portion to the proximal end portion of the inner tube 110 is, for example, 1200 mm to 2700 mm, preferably 1100 mm to 2600 mm. Although the inner tube 110 and the outer tube 120 have a substantially circular cross-sectional shape, the cross-sectional shape does not necessarily have to be a perfect circle, and may be, for example, an elliptical shape. The average outer diameter of the outer tube 120 is preferably 0.3 mm to 3 mm, and preferably 0.5 mm to 2 mm. The average outer diameter of the inner tube 110 is preferably 0.2 mm to 2.8 mm, and preferably 0.25 mm to 1.85 mm.

図1に示されるようにバルーン200はシャフト100の先端部近傍に配置されており、膀胱内で膨張可能である。なおシャフト100の先端部近傍とは、シャフト100の長さをSとすると、例えばシャフト100の先端部から0.1S〜0.2Sの位置を規定するものである。図2に示されるようにバルーン200は内管110の先端部と外管120の先端部にそれぞれ接着されて、外管120の開口部121を包むように配置されている。バルーン200は柔軟性、気密性及び伸縮性を有する材料を有する素材、例えばナイロン、ポリエチレンテレフタレート樹脂、ポリアミド系樹脂等の薄膜から構成されている。   As shown in FIG. 1, the balloon 200 is disposed in the vicinity of the distal end portion of the shaft 100 and is inflatable in the bladder. Note that the vicinity of the tip of the shaft 100 defines the position of 0.1S to 0.2S from the tip of the shaft 100, for example, where S is the length of the shaft 100. As shown in FIG. 2, the balloon 200 is bonded to the distal end portion of the inner tube 110 and the distal end portion of the outer tube 120 so as to wrap around the opening 121 of the outer tube 120. The balloon 200 is composed of a material having a material having flexibility, airtightness, and stretchability, for example, a thin film such as nylon, polyethylene terephthalate resin, polyamide resin or the like.

バルーン200を構成する薄膜の厚みは必ずしも限定されないが、例えば、収縮時において10μm〜500μmである。内管110の外周面と外管120の内周面との間を延びる第2ルーメンを流れる流体がバルーン200に供給されると、バルーン200は拡張することができる。一方、拡張したバルーン200内の流体が第2ルーメンに戻るとバルーン200は収縮する。こうしてバルーン200の拡張及び収縮を制御することができる。   Although the thickness of the thin film which comprises the balloon 200 is not necessarily limited, For example, they are 10 micrometers-500 micrometers at the time of shrinkage | contraction. When the fluid flowing through the second lumen extending between the outer peripheral surface of the inner tube 110 and the inner peripheral surface of the outer tube 120 is supplied to the balloon 200, the balloon 200 can be expanded. On the other hand, when the fluid in the expanded balloon 200 returns to the second lumen, the balloon 200 contracts. In this way, the expansion and contraction of the balloon 200 can be controlled.

本発明において、バルーン200が拡張した際、バルーン200は例えば1mm〜10mm、好ましくは2mm〜5mmの外径を有する。なお、図1において拡張したバルーン200の形状は略球状を示しているが、拡張したバルーンの形状はこれに限定されず例えば、楕円球状や他の幾何学的形状を有していてもよい。   In the present invention, when the balloon 200 is expanded, the balloon 200 has an outer diameter of, for example, 1 mm to 10 mm, preferably 2 mm to 5 mm. In addition, although the shape of the expanded balloon 200 in FIG. 1 shows a substantially spherical shape, the shape of the expanded balloon is not limited to this, and may have an elliptical spherical shape or other geometric shapes, for example.

図3に示されるように、陰部神経は仙骨神経叢から分岐し、骨盤底を走行し尿道口・生殖器に達する。上述したように、本発明においては、陰部神経に電気刺激を与える刺激電極300を、あえて陰部神経から離間した位置である膀胱頸部近傍に位置させるが、そのために刺激電極300は膀胱内で膨張可能なバルーン200の基端部側に設けられている。膀胱頸部は膀胱と尿道とをつなぐ部分であり、図3では膀胱入口として示されている。なお図3では女性の場合の陰部神経の流れを記載しているが、本発明の適用対象は女性に限定されるものではなく男性にも適用可能であり、更には成人のみならず小児にも適用可能である。   As shown in FIG. 3, the pudendal nerve branches off from the sacral plexus, travels through the pelvic floor, and reaches the urethral orifice / genital organ. As described above, in the present invention, the stimulation electrode 300 for applying electrical stimulation to the pudendal nerve is intentionally positioned in the vicinity of the bladder neck, which is a position away from the pudendal nerve. For this reason, the stimulation electrode 300 is expanded in the bladder. It is provided on the proximal end side of the possible balloon 200. The bladder neck is a portion connecting the bladder and the urethra, and is shown as a bladder inlet in FIG. Although FIG. 3 shows the flow of the pudendal nerve in the case of a woman, the application target of the present invention is not limited to a woman and can be applied to a man. Applicable.

図4(A)に示されるように、刺激電極を陰部神経近傍に位置させた場合にあっては患者の体動等により刺激電極が対外に露出してしまう場合がある。一方、図4(B)に示されるように、刺激電極を膀胱頸部近傍に位置させた場合は、意外にも、陰部神経への電気刺激は可能であり、且つ、患者の体動等があっても安定的に刺激電極を体内に留置することが可能である。   As shown in FIG. 4A, when the stimulation electrode is positioned in the vicinity of the pudendal nerve, the stimulation electrode may be exposed to the outside due to the patient's body movement or the like. On the other hand, as shown in FIG. 4 (B), when the stimulation electrode is positioned in the vicinity of the bladder neck, unexpectedly, electrical stimulation to the pudendal nerve is possible, and the patient's body movement or the like Even if it exists, it is possible to stably place the stimulation electrode in the body.

図1に示されるように、刺激電極300は、先端部側に位置する第1電極310と基端部側に位置する第2電極320との電極対からなり、具体的にはバイポーラ電極対である。バルーン200の基端側端部210と第1電極310(第1電極310の先端側端部)との距離Lは、例えば10mm乃至20mmであることが好ましい。後述する実施例において示されるが、距離Lが10mm及び20mmの場合、陰部神経から離間した位置に刺激電極が位置しているにもかかわらず正確なBCRモニタリングが可能である。   As shown in FIG. 1, the stimulation electrode 300 is composed of an electrode pair of a first electrode 310 located on the distal end side and a second electrode 320 located on the proximal end side, specifically, a bipolar electrode pair. is there. The distance L between the proximal end 210 of the balloon 200 and the first electrode 310 (the distal end of the first electrode 310) is preferably 10 mm to 20 mm, for example. As shown in the examples described later, when the distance L is 10 mm and 20 mm, accurate BCR monitoring is possible even though the stimulation electrode is located at a position away from the pudendal nerve.

第1電極310と第2電極320との間隔(第1電極310の先端側端部と第2電極320の基端側端部との間隔)は、特に限定されるものではないが例えば8.0mm〜12.0mmであり、好ましくは9.0mm〜11.0mmであり、特に好ましくは10.0mmである。   The interval between the first electrode 310 and the second electrode 320 (the interval between the distal end portion of the first electrode 310 and the proximal end portion of the second electrode 320) is not particularly limited, but is, for example, 8.0 mm. ˜12.0 mm, preferably 9.0 mm to 11.0 mm, particularly preferably 10.0 mm.

第1電極310及び第2電極320は、例えば、直径0.06〜0.10mm好ましくは直径0.08mmのウレタンコーティングされた白金線が外管120の管径にそって複数回巻き付けられて形成されている。第1電極310は例えば陰極であり、第2電極320は例えば陽極である。   The first electrode 310 and the second electrode 320 are formed, for example, by winding a urethane-coated platinum wire having a diameter of 0.06 to 0.10 mm, preferably 0.08 mm, around the outer tube 120 a plurality of times. The first electrode 310 is, for example, a cathode, and the second electrode 320 is, for example, an anode.

刺激電極300は導線を介して図示されない高周波電源から電力供給を受ける。即ち、第1電極310及び第2電極320から導かれるウレタンコーティングされた白金線は第1ルーメン内部を通過し(図示省略)、第2ハブ140の側部に設けられたモールド部400から外界へ導かれ、リード線500として延出して、高周波電源に接続可能な接続端子600に連絡する。   The stimulation electrode 300 is supplied with electric power from a high-frequency power source (not shown) through a conductive wire. That is, the urethane-coated platinum wire led from the first electrode 310 and the second electrode 320 passes through the inside of the first lumen (not shown), and goes from the mold part 400 provided on the side of the second hub 140 to the outside. The lead wire 500 is extended as a lead wire 500 and connected to a connection terminal 600 that can be connected to a high-frequency power source.

術者が図示されない操作パネルにて高周波処置を指示すると刺激電極300に対して高周波電力が供給され、第1電極310及び第2電極320の間に高周波電流が流れる。第1電極310及び第2電極320に印加される電流は、人体に悪影響を与えず且つ正確なBCRモニタリングを可能とする範囲であれば特に限定されるものではなく、例えば20mA〜40mAであり、好ましくは25mA〜35mAであり、特に好ましくは30mAである。   When the surgeon instructs high frequency treatment on an operation panel (not shown), high frequency power is supplied to the stimulation electrode 300, and high frequency current flows between the first electrode 310 and the second electrode 320. The current applied to the first electrode 310 and the second electrode 320 is not particularly limited as long as it does not adversely affect the human body and allows accurate BCR monitoring, and is, for example, 20 mA to 40 mA. Preferably it is 25mA-35mA, Most preferably, it is 30mA.

次に本実施形態にかかる電極付挿入体900の使用形態について説明する。患者に対して全身麻酔導入後、仰臥位の患者の尿道内にシャフト100をゆっくりと挿入する。バルーン200が膀胱頸部を通過して膀胱内部に侵入したことを確認してから第2ハブ140より拡張液を供給してバルーン200を拡張する。刺激電極300はバルーン200の基端部側に設けられているため、シャフト100が尿道内に挿入後は刺激電極300は膀胱頸部近傍に位置する(図4(B))。接続端子600を高周波電源に接続後、刺激電極300に対して高周波電力を供給する。これにより刺激電極300から陰部神経に対して電気刺激を加えることが可能となる。   Next, a usage pattern of the electrode-equipped insert 900 according to the present embodiment will be described. After introducing general anesthesia to the patient, the shaft 100 is slowly inserted into the urethra of the patient in the supine position. After confirming that the balloon 200 has entered the bladder through the bladder neck, an expansion fluid is supplied from the second hub 140 to expand the balloon 200. Since the stimulation electrode 300 is provided on the proximal end side of the balloon 200, the stimulation electrode 300 is positioned in the vicinity of the bladder neck after the shaft 100 is inserted into the urethra (FIG. 4B). After connecting the connection terminal 600 to the high frequency power source, high frequency power is supplied to the stimulation electrode 300. As a result, electrical stimulation can be applied from the stimulation electrode 300 to the pudendal nerve.

(実施例1)
図5に示されるように、本実施例にかかる電極付挿入体は下記に示すものを使用した。バルーンの外径は14Fr(外径4.7mm)であり、シャフトの外管の先端部から基端部までの距離は1000mm、外管の外径は2mmであった。刺激電極においては第1電極(陰極)及び第2電極(陽極)はともにウレタンコーティングされた直径0.08mmの白金線をシャフトの外管に巻き付けて形成し、第1電極と第2電極との距離は10.0mmとした。バルーンの基端側端部と第1電極との距離Lは10mmとした。
Example 1
As shown in FIG. 5, the electrode-inserted body according to this example used the following. The outer diameter of the balloon was 14 Fr (outer diameter 4.7 mm), the distance from the distal end portion to the proximal end portion of the outer tube of the shaft was 1000 mm, and the outer diameter of the outer tube was 2 mm. In the stimulation electrode, both the first electrode (cathode) and the second electrode (anode) are formed by winding a platinum wire with a diameter of 0.08 mm around the outer tube of the shaft, and the distance between the first electrode and the second electrode. Was 10.0 mm. The distance L between the proximal end of the balloon and the first electrode was 10 mm.

全身麻酔導入後、仰臥位でBCRモニタリングのために患者の尿道内に本実施例にかかる電極付挿入体を静かに挿入した。その後、腹臥位へと姿勢変換させた。記録電極としては肛門括約筋に左右1対合計2本の針電極を刺入留置した。筋電計は日本光電社製のNeuromaster(登録商標)を使用し、刺激は30mA、0.5Hz、0.2〜0.5msec durationで行い、刺激による筋電図波形を計測した。   After introduction of general anesthesia, the electrode-attached insert according to this example was gently inserted into the urethra of the patient for BCR monitoring in the supine position. After that, the posture was changed to prone position. As a recording electrode, a pair of left and right needle electrodes in total was inserted into the anal sphincter. A neuromaster (registered trademark) manufactured by Nihon Kohden Co., Ltd. was used as the electromyograph, stimulation was performed at 30 mA, 0.5 Hz, and 0.2 to 0.5 msec duration, and the electromyogram waveform due to the stimulation was measured.

従来法によるBCRモニタリングでは、全身麻酔導入後、仰臥位で患者の陰核にシール電極を貼付した。肛門括約筋の収縮の検出は本実施例と同じ手法によるものであった。   In conventional BCR monitoring, a seal electrode was applied to the patient's clitoris in the supine position after introducing general anesthesia. The anal sphincter contraction was detected by the same technique as in this example.

結果を図6に示す。図6(A)は、従来法及び本発明のそれぞれにおいてのコントロール(手術開始前)のBCR振幅を示す。図6(B)は、従来法及び本発明のそれぞれにおいての手術終了時のBCR振幅を示す。従来法ではコントロールと比較して振幅の低下が著しかった。これは貼付したシール電極が一部剥離したことに起因すると考えられる。   The results are shown in FIG. FIG. 6 (A) shows the BCR amplitude of the control (before the start of surgery) in each of the conventional method and the present invention. FIG. 6B shows the BCR amplitude at the end of surgery in the conventional method and each of the present invention. In the conventional method, the decrease in amplitude was significant compared to the control. This is considered to be due to the part of the attached seal electrode being peeled off.

(実施例2)
次に、バルーンの基端側端部と第1電極との距離Lを20mmとした以外は実施例1と同様にしてBCR振幅を即位した。
(Example 2)
Next, the BCR amplitude was determined in the same manner as in Example 1 except that the distance L between the proximal end of the balloon and the first electrode was 20 mm.

結果を図7に示す。図7(A)は、従来法及び本発明のそれぞれにおいてのコントロール(手術開始前)のBCR振幅を示す。図7(B)は、従来法及び本発明のそれぞれにおいての手術終了時のBCR振幅を示す。本発明の電極挿入体を使用した場合にあっては手術開始前及び手術終了時においてBCR振幅の変化は乏しく安定してBCR振幅のモニタリングが可能となることが判明した。従来法ではコントロールと比較して振幅の低下が著しかった。   The results are shown in FIG. FIG. 7 (A) shows the BCR amplitude of the control (before the start of surgery) in each of the conventional method and the present invention. FIG. 7B shows the BCR amplitude at the end of surgery in the conventional method and each of the present invention. When the electrode insert of the present invention was used, it was found that the change in BCR amplitude was scarce before the start of surgery and at the end of the surgery, and the BCR amplitude could be monitored stably. In the conventional method, the decrease in amplitude was significant compared to the control.

(実施例3)
次に、バルーンの基端側端部と第1電極との距離Lを5mmとした以外は実施例1と同様にしてBCR振幅を測定した。従来法と比較すると安定的にBCR振幅を測定することができたが、希に刺激電極が患者の膀胱内に侵入することがあった。
(Example 3)
Next, the BCR amplitude was measured in the same manner as in Example 1 except that the distance L between the proximal end of the balloon and the first electrode was 5 mm. Compared with the conventional method, the BCR amplitude could be measured stably, but the stimulation electrode rarely entered the patient's bladder.

(実施例4)
次に、バルーンの基端側端部と第1電極との距離Lを40mm又は60mmとした以外は実施例1と同様にしてBCR振幅を測定した。従来法と比較すると安定的にBCR振幅を測定することができたが、希に刺激電極が患者の尿道内から脱出することがあった。
Example 4
Next, the BCR amplitude was measured in the same manner as in Example 1 except that the distance L between the proximal end of the balloon and the first electrode was 40 mm or 60 mm. Compared with the conventional method, the BCR amplitude could be measured stably, but the stimulation electrode rarely escaped from the urethra of the patient.

以上説明したように、本発明にかかる電極付挿入体を用いることにより、正確にBCRモニタリングが可能となり、特に患者が女性や小児の場合に有益である。   As described above, BCR monitoring can be performed accurately by using the electrode-attached insert according to the present invention, which is particularly beneficial when the patient is a woman or a child.

BCRモニタリングに利用できる。   It can be used for BCR monitoring.

100:シャフト
110:内管
120:外管
130:第1ハブ
140:第2ハブ
200:バルーン
300:刺激電極
310:第1電極
320:第2電極
400:モールド部
500:リード線
600:接続端子
900:電極付挿入体
100: Shaft
110: Inner pipe
120: Outer pipe
130: Hub 1
140: Second hub
200: Balloon
300: Stimulation electrode
310: First electrode
320: Second electrode
400: Mold part
500: Lead wire
600: Connection terminal
900: Insert with electrode

Claims (3)

尿道内に挿入される細長いシャフトと、
前記シャフトの先端部近傍に配置され、膀胱内で膨張可能なバルーンと、
前記シャフトの尿道内挿入時に膀胱頸部近傍に位置して陰部神経を刺激する、バルーン基端部側に設けられる刺激電極と、を有することを特徴とする、
球海綿体反射モニタリングに使用される、電極付挿入体。
An elongated shaft that is inserted into the urethra;
A balloon disposed near the tip of the shaft and inflatable in the bladder;
A stimulating electrode provided on the proximal side of the balloon for stimulating the pudendal nerve located in the vicinity of the bladder neck when the shaft is inserted into the urethra,
Insert with electrode used for spherical cavernous reflection monitoring.
前記刺激電極は、先端部側に位置する第1電極と基端部側に位置する第2電極との電極対からなり、前記バルーンの基端側端部と前記第1電極との距離は10mm乃至20mmであることを特徴とする請求項1に記載の電極付挿入体。   The stimulation electrode is composed of an electrode pair of a first electrode located on the distal end side and a second electrode located on the proximal end side, and the distance between the proximal end portion of the balloon and the first electrode is 10 mm. The insert with electrode according to claim 1, wherein the insert has an electrode of 20 mm. 前記第1電極と前記第2電極との間隔は8.0mm〜12.0mmであることを特徴とする請求項2に記載の電極付挿入体。   The electrode-inserted body according to claim 2, wherein a distance between the first electrode and the second electrode is 8.0 mm to 12.0 mm.
JP2017181205A 2017-09-21 2017-09-21 Insertion body with electrodes Pending JP2019055026A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2017181205A JP2019055026A (en) 2017-09-21 2017-09-21 Insertion body with electrodes
PCT/JP2018/022321 WO2019058656A1 (en) 2017-09-21 2018-06-12 Electrode-equipped insert

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017181205A JP2019055026A (en) 2017-09-21 2017-09-21 Insertion body with electrodes

Publications (1)

Publication Number Publication Date
JP2019055026A true JP2019055026A (en) 2019-04-11

Family

ID=65809633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017181205A Pending JP2019055026A (en) 2017-09-21 2017-09-21 Insertion body with electrodes

Country Status (2)

Country Link
JP (1) JP2019055026A (en)
WO (1) WO2019058656A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113331938B (en) * 2021-06-25 2022-06-17 武汉半边天医疗技术发展有限公司 Micro-plastic temperature control radio frequency diagnosis and treatment system

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017500072A (en) * 2013-11-01 2017-01-05 メドトロニック・ゾーメド・インコーポレーテッド Foley catheter with ring electrode

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8439845B2 (en) * 2007-09-25 2013-05-14 Uroval, Inc. Obtaining measurements of muscle reflexes for diagnosis of patient symptoms

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017500072A (en) * 2013-11-01 2017-01-05 メドトロニック・ゾーメド・インコーポレーテッド Foley catheter with ring electrode

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
J. NORDLING ET AL.: ""Evoked Response of Bulbocavernosus Reflex"", EUROPEAN UROLOGY, vol. 5, no. 1, JPN6021004389, 31 December 1979 (1979-12-31), pages 36 - 38, ISSN: 0004443338 *
SARICA YAKUP ET AL.: ""Electrophysiological Correlates of Sensory Innervation of the Vesico-Urethral Junction and Urethra", NEUROUROLOGY AND URODYNAMICS, vol. 6, no. 6, JPN6020043104, 31 December 1988 (1988-12-31), pages 477 - 484, ISSN: 0004383969 *
W. E. BRADLEY ET AL.: ""Detrusor and urethral electromyelography"", THE JOURNAL OF UROLOGY, vol. 114, no. 6, JPN6021004388, 31 December 1975 (1975-12-31), pages 891 - 894, ISSN: 0004443337 *
古屋聖児 他: "「誘発筋電図による球海綿体反射の伝導時間測定」", 日本泌尿器科學會雑誌, vol. 74, no. 1, JPN6021004386, 31 December 1983 (1983-12-31), pages 15 - 24, ISSN: 0004443335 *
米田勝紀 他: "「誘発筋電図法による球海綿体反射の検討」", 泌尿器科紀要, vol. 30, no. 9, JPN6021004387, 30 September 1984 (1984-09-30), pages 1207 - 1211, ISSN: 0004443336 *

Also Published As

Publication number Publication date
WO2019058656A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
JP7133058B2 (en) Urination catheter and method for accelerated introduction into urinary tract
US20100076425A1 (en) Urological balloon catheter
US7593778B2 (en) Electrosurgical device with improved visibility
US20090143649A1 (en) Speculum for the electropharmacological treatment of vaginal diseases
US9289597B2 (en) Guide catheter having vasomodulating electrodes
US9750564B2 (en) Flexible catheter for high-frequency therapy of biological tissue and method of using same
JP2019512291A5 (en)
CN113613710A (en) Devices, systems, and methods for treating neurogenic bladder
WO2004043260A1 (en) Catheter for diagnosing interstitial cystitis
JP6118435B2 (en) Catheter for monitoring biological environment
JP2019055026A (en) Insertion body with electrodes
CN215306625U (en) Pulse ablation electrode assembly and pulse ablation catheter
JP2006247344A (en) Guide wire with electrodes for medical use
US9037211B1 (en) Bladder monitoring device
JP6055361B2 (en) Counter electrode and electrical detachable in-vivo indwelling device kit
JP7476188B2 (en) Devices, systems and methods for the treatment of neurogenic bladder
WO2017173606A1 (en) Bipolar incision knife
JP3837082B2 (en) Receptoscope device
CN116115320A (en) Pulse ablation device
UA78491C2 (en) Method for treating specific mycotic and nonspecific uretroprostatitis

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200626

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210216

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210907

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210907

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210921

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210928

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20211105

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20211109

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20211207

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20220301

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20220329

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20220329